CTRI/2021/03/032053已完成4 期
An open label, multicentric, randomized, comparative clinical trial to evaluate safety and efficacy of fixed-dose combination of Trypsin 48 mg, Bromelain 90 mg, Rutoside 100 mg and Diclofenac 50 mg tablet in comparison to Diclofenac 50 mg tablet in wound management.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients aged 18 to 65 years.
- •2. Patients with elective clean and uncontaminated surgery.
- •3. Patients willing to sign informed consent.
排除标准
- •1. Patients with known hypersensitivity to any of the study drugs.
- •2. Patients with severe renal impairment.
- •3. Patients with severe hepatic impairment.
- •4. Patients with hereditary coagulation disorder.
- •5. Women who are pregnant or lactating.
- •6. Patients with any other condition that, in the opinion of the investigator, does not justify his/her inclusion in the study.
研究者
相似试验
尚未招募
3 期
Role of Oro-T ORAL RINSE (IN-100000264) in Mitigation and Treatment ofOral Mucositis during Cancer Radiotherapy with or without Chemotherapy in Head and NeckCTRI/2021/09/036497The Himalaya Drug Company
已完成
3 期
A clinical trial to study the efficacy and safety of combination drugs of Pregabalin Prolonged Release and Etoricoxib in comparison to single therapy of Etoricoxib in patients having chronic low back pain in India.CTRI/2018/10/015886Sun Pharma Laboratories Limited319
已完成
3 期
A clinical trial to study the effects of two drugs, Fixed dose combination of tablets of Rosuvastatin 5 mg and Fenofibrate 160mg with Rosuvastatin 5mg alone in patients with dyslipidemiaCTRI/2010/091/000147M/s. Ravenbhel Healthcare Pvt. Ltd.200
进行中（未招募）
不适用
An open label, multi-center, randomized, comparative Phase IIIb study to compare efficacy and safety of intravenous (i.v.) daptomycin with that of Semi-synthetic Penicillins (SSPs) or vancomycin in the treatment of elderly patients (aged ≥ 65 years) with complicated Skin and Soft Tissue Infections (cSSTIs) - NDComplicated skin and soft tissue infectionsEUCTR2009-014391-22-ITovartis Pharma AG146
进行中（未招募）
不适用
An open label, multi-center, randomized, comparative Phase IIIb study to compare efficacy and safety of intravenous (i.v.) daptomycin with that of Semi-synthetic Penicillins (SSPs) or vancomycin in the treatment of elderly patients (aged = 65 years) with complicated Skin and Soft Tissue Infections (cSSTIs)complicated skin and soft tissue infections.EUCTR2009-014391-22-DEovartis Pharma AG146